Stock vs Stock Comparison

Zimmer Biomet Holdings, Inc. vs Johnson & Johnson

ZBH and JNJ are evenly matched across key metrics.

ZBH$84.98
JNJ$223.24

🏆 Tale of the Tape

44
ZBHJNJ
8.6%Profitability (Net Margin)28.5%
21.3xValuation (P/E)26.1x
4.3%Efficiency (ROIC)18.3%
4/9Health (Piotroski F)4/9
2.4Safety (Altman Z)4.0
7.2%Growth (Rev YoY)6.0%
-0.24Risk (Sharpe 1Y)2.69
0.82xBalance Sheet (D/E)1.44x
5.78%FCF Yield3.25%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.214
252-Day Correlation
0.146
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricZBHJNJ
Market Cap$15.9B$542.4B
P/E Ratio21.3x26.1x
Forward P/E9.1x17.7x
P/B1.26x6.68x
Dividend Yield1.17%2.38%
Beta0.470.26

Quantitative Metrics

MetricZBHJNJ
DCF Fair Value$126.26$134.24
DCF Upside+32.4%-43.6%
Piotroski F4/94/9
Altman Z2.413.97
Beneish M-2.57-2.27
FCF Yield5.78%3.25%
Net Debt/EBITDA2.9x0.5x
ROIC4.3%18.3%
WACC7.4%7.7%
ROIC – WACC-3.0pp10.5pp
Gross Margin69.7%67.9%
Net Margin8.6%28.5%
Rev Growth YoY7.2%6.0%
Sharpe (1Y)-0.242.69
Max Drawdown 3Y-16.0%
FCF Payout Ratio13%64%

ZBH Price

Loading chart...

JNJ Price

Loading chart...

ETF Exposure

ZBH found in:

MOAT2.26%
XHE1.56%
XLV0.32%
VOE0.29%
ONEV0.28%
VHT0.26%
RSP0.18%
VO0.16%
VFVA0.12%
SCHV0.07%
VTV0.06%
IWD0.06%
SPYV0.06%
ONEO0.05%
VONV0.05%
ESGV0.04%
SPLG0.03%
SCHX0.03%
IVV0.03%
VOO0.03%
SCHB0.03%
ITOT0.03%
SPY0.03%
SPTM0.03%
URTH0.02%
QUS0.02%
VTI0.02%
VONE0.02%
ACWI0.02%

JNJ found in:

XLV10.42%
IYH10.14%
VHT8.84%
HDV6.84%
MTUM3.76%
DIA2.83%
MGV2.75%
DGRO2.64%
VIG2.49%
VYM2.30%
VTV2.16%
DGRW2.02%
SCHV2.02%
IWD1.94%
QUS1.81%
XPH1.74%
VONV1.69%
NOBL1.58%
VFMV1.42%
VFMO1.02%
SCHX0.96%
SPYG0.94%
SDY0.93%
VOO0.90%
SCHB0.90%
SPY0.87%
IVV0.85%
VONE0.84%
SPTM0.81%
VTI0.80%
SPYV0.79%
SPLG0.76%
ITOT0.75%
URTH0.70%
ACWI0.57%
VT0.49%
RSP0.21%
VFVA0.15%
ONEO0.05%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ZBH vs JNJ: Head-to-Head Analysis

Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ) represent two companies in the Healthcare sector. Our quantitative Tale of the Tape shows these companies are evenly matched across profitability, valuation, and risk metrics.

In terms of capital efficiency, ZBH generates a return on invested capital (ROIC) of 4.3% compared to JNJ's 18.3%. This suggests JNJ is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ZBH and JNJ is 0.214, indicating low correlation, making them an effective diversification pair in a portfolio context.

ZBH appears in 29 ETFs tracked by SecuritiesDB, while JNJ appears in 39 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ZBH or JNJ?

Our quantitative analysis compares ZBH and JNJ across nine fundamental dimensions. ZBH and JNJ are evenly matched across key metrics. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ZBH and JNJ correlated?

The 252-day correlation between ZBH and JNJ is 0.214. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.